Testing version — LOERadar is in active testing. Features and data may change.
ROZLYTREK (ENTRECTINIB) | LOERadar
Not in the current Orange Book — This application is not listed in FDA's current Orange Book data files (no listed patents or exclusivities). Product and approval data shown are from FDA's Drugs@FDA database.
ROZLYTREK
NDANot in Orange Book
ENTRECTINIB | N212726 | GENENTECH INC
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
No ANDA patent litigation cases (NOS 835) matched from PACER
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (2)
Sort:
#001 — 100MG
▴
CAPSULE;ORAL | Approved: Aug. 15, 2019
No patent or exclusivity listings for this strength.